Cambridge Investment Research Advisors »

Ocular Therapeutix shares owned by Cambridge Investment Research Advisors

Quarter-by-quarter ownership of Ocular Therapeutix (OCUL) shares owned by Cambridge Investment Research Advisors from 13F filings

Historical chart of Cambridge Investment Research Advisors investment in Ocular Therapeutix

Tip: Access up to 7 years of quarterly data

All positions including Ocular Therapeutix held by Cambridge Investment Research Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocular Therapeutix by Cambridge Investment Research Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $340k 29k 11.68
2025-06-30 $224k 24k 9.29

More positions owned by Cambridge Investment Research Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple Inc Com (AAPL)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corp Com (MSFT)
Amazon Com Inc Com (AMZN)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
SPDR S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Meta Platforms Inc Cl A (META)
Vanguard Index Fds Growth Etf (VUG)
Spdr Series Trust Portfolio S&P500 (SPLG)

View all positions for Cambridge Investment Research Advisors

Top funds holding Ocular Therapeutix

FMR
VR Adviser
Summer Road
Deep Track Capital
BlackRock
venBio Select Advisor
Vanguard Group
TCG Crossover Management
Citadel Advisors
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Paradigm Biocapital Advisors
State Street Corporation
Alliancebernstein

View all funds holding Ocular Therapeutix